Weekly Mind Reader: Treating OCD and Compulsive Sexual Behavior

by Denis Storey
February 16, 2024 at 10:52 AM UTC

The Primary Care Companion for CNS Disorders published a paper that suggests the use of trait mindfulness-based interventions might help reduce anxiety levels in students who present with severe problematic social media use.

Primary Care Companion just published a report that illustrates a unique case of concomitant OCD and compulsive sexual behavior treated with sertraline and naltrexone.

Treatment of OCD With Concomitant Compulsive Sexual Behavior

Contrary to popular belief, compulsive sexual behavior disorder is not classified within the obsessive-compulsive spectrum disorders but rather as an impulse control disorder.

Compulsive sexual behavior disorder is classified under impulse control disorders in ICD-11, rather than within obsessive-compulsive spectrum disorders. While the placement of this disorder in DSM-5 is unclear, there’s the exploration of its co-occurrence with OCD, with rates estimated around 5%-14%. Research suggests positive outcomes with naltrexone treatment for compulsive sexual behavior (CSB), although its efficacy for OCD spectrum symptoms is limited.

A case report details a 58-year-old man with moderate OCD and chronic CSB. Sertraline effectively reduced his OCD symptoms but had no impact on CSB. Naltrexone was added, resulting in significant improvement in CSB while maintaining stable OCD symptoms. Withdrawal and subsequent reinstatement of naltrexone demonstrated its efficacy in controlling CSB.

This case prompts consideration for the classification of dysfunctional sexual behaviors, which exhibit compulsive traits distinct from OCD compulsions, involve some pleasure, and vary in treatment response. Impulse control disorder or addictive disorder categories might better characterize these behaviors, especially considering the positive response to naltrexone.

IN OTHER PSYCHIATRY AND NEUROLOGY NEWS

  • Dr. Ostacher discusses a review by Rodas and others, pointing to a need for clear answers on how best to advise patients with PTSD and other psychiatric illnesses about cannabis use.
  • A reader writes to question the emergence of Mpox cases globally, its treatment with tecovirimat and cidofovir, and their potential interactions with psychotropic medications, emphasizing the need for further research due to limited data.
  • Recognition of hypoactive delirium should prompt the search for its underlying etiologies, with initial attention paid to life-threatening or emergent causes.
  • New research reveals that homelessness drives alcohol and drug overdose deaths.
  • University of Pittsburgh researchers found that familiar scents could aid in memory recall for individuals with depression.

NEW AT CME INSTITUTE

Click to earn free accredited CME credit.

Case Studies in HAE: Diagnosing, Treating, and Managing the Patient With Hereditary Angioedema

Optimizing Mental Health for Women: Recognizing and Treating Mood Disorders Throughout the Lifespan

Staying Up to Date with Evolving Postpartum Depression Pathophysiology and Treatment Research

Original Research

A Fully Remote Randomized Trial of Transcranial Alternating Current Stimulation for the Acute Treatment of Major Depressive Disorder

Rapid improvement in depression was associated with tACS, particularly for women. Patients can use tACS treatment on their own at home, and it is associated with minimal adverse events.

Philip R. Gehrman and others

Rounds in the General Hospital

Caring for Traumatized Elders: Lessons Learned From Trauma-Informed Care

Patients with a history of trauma may experience heightened anxiety and fear when faced with medical settings, examinations, or treatments.

Dominique Popescu and others